tradingkey.logo

Park Ha Biological Technology Co Ltd

PHH
0.385USD
0.0000.00%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
11.31MMarktkapitalisierung
--KGV TTM

Park Ha Biological Technology Co Ltd

0.385
0.0000.00%

mehr Informationen über Park Ha Biological Technology Co Ltd Unternehmen

Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The Company mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The Company's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The Company mainly conducts its business in domestic market.

Park Ha Biological Technology Co Ltd Informationen

BörsenkürzelPHH
Name des UnternehmensPark Ha Biological Technology Co Ltd
IPO-datumDec 27, 2024
CEOZhang (Xiaoqiu)
Anzahl der mitarbeiter31
WertpapierartOrdinary Share
GeschäftsjahresendeDec 27
Addresse- -
Stadt- -
BörseNASDAQ Capital Market Consolidated
Land- -
Postleitzahl- -
Telefon- -
Website- -
BörsenkürzelPHH
IPO-datumDec 27, 2024
CEOZhang (Xiaoqiu)

Führungskräfte von Park Ha Biological Technology Co Ltd

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Mr. Xiaozhong Yu
Mr. Xiaozhong Yu
Independent Director Nominee
Independent Director Nominee
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--

Umsatzaufteilung

FY2024
FY2023
FY2022
FY2021
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
China (Mainland)
2.38M
0.00%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Xiaoqiu Holding Ltd
51.91%
Changxin International Ltd Partnership
6.81%
XTX Markets LLC
0.12%
Two Sigma Investments, LP
0.07%
Geode Capital Management, L.L.C.
0.05%
Andere
41.04%
Aktionäre
Aktionäre
Anteil
Xiaoqiu Holding Ltd
51.91%
Changxin International Ltd Partnership
6.81%
XTX Markets LLC
0.12%
Two Sigma Investments, LP
0.07%
Geode Capital Management, L.L.C.
0.05%
Andere
41.04%
Aktionärstypen
Aktionäre
Anteil
Corporation
58.72%
Venture Capital
0.12%
Hedge Fund
0.07%
Investment Advisor/Hedge Fund
0.05%
Research Firm
0.01%
Investment Advisor
0.01%
Andere
41.02%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
18
96.81K
0.26%
-57.60K
2025Q3
15
103.15K
0.30%
+40.70K
2025Q2
9
21.62M
81.98%
-25.58K
2025Q1
8
21.60M
81.90%
-29.47K
2024Q4
6
21.63M
82.55%
+21.63M

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Xiaoqiu Holding Ltd
19.05M
56.24%
--
--
Feb 24, 2025
Changxin International Ltd Partnership
2.50M
7.38%
--
--
Feb 24, 2025
XTX Markets LLC
43.55K
0.13%
+43.55K
--
Sep 30, 2025
Two Sigma Investments, LP
26.69K
0.08%
+26.69K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
16.85K
0.05%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
5.34K
0.02%
-1.68K
-23.94%
Sep 30, 2025
UBS Financial Services, Inc.
5.00K
0.01%
+3.53K
+239.88%
Sep 30, 2025
Morgan Stanley Smith Barney LLC
780.00
0%
+486.00
+165.31%
Sep 30, 2025
RBC Capital Markets Wealth Management
19.00
0%
--
--
Sep 30, 2025
Citadel Advisors LLC
--
0%
-21.23K
-100.00%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Invesco Golden Dragon China ETF
0%
Invesco Golden Dragon China ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI